Olympus Corporation (7733.T)

2.543,50 -9,50 (-0,37%) Börsenschluss: 03:15PM JST

Olympus Corporation

Shinjuku Monolith
3-1 Nishi-Shinjuku 2-chome Shinjuku-ku
Tokyo 163-0914
Japan
81 3 3340 2111
https://www.olympus-global.com

Sektor(en): Healthcare
Branche: Medical Instruments & Supplies
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Yasuo Takeuchi	Representative Executive Officer, ESG Officer & Executive Chairman	382M	N/A	1957
Mr. Andre Roggan	Executive Officer & CTO	230M	N/A	N/A
Stephen Kneebone	Corporate Officer & Chief Information Officer	734M	N/A	N/A
Mr. Stefan Kaufmann	Representative Executive Officer, President, CEO & Director	661M	N/A	1968
Tatsuya Izumi	Executive Officer & CFO	N/A	N/A	1964
Takaaki Sakurai	Vice President of Investor Relations	N/A	N/A	N/A
Ms. Eva Gardyan-Eisenlohr	Chief Compliance Officer, Global Head of Governance, Risk & Compliance	N/A	N/A	N/A
Mr. Neil Boyden Tanner	Global General Counsel	N/A	N/A	N/A
Shigeto Ohtsuki	Executive Officer & Chief Human Resources Officer	N/A	N/A	N/A
Mr. Tetsuo Kobayashi	Executive Officer and Chief Manufacturing & Supply Officer	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in JPY.

Beschreibung

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials, such as synthetic bone filler, and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.

Corporate Governance

Olympus Corporations ISS Governance QualityScore, Stand 1. Mai 2024, lautet 1. Die grundlegenden Scores sind Audit: 1, Vorstand: 1, Shareholderrechte: 5, Kompensation: 1.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.